Asklepios Klinik Altona

Recent papers from Asklepios Klinik Altona

1. Left Atrial Appendage Closure in Patients Considered Unsuitable for Oral AnticoagulationJournal of the American College of Cardiology · 2026
2. The LEASH Trial: Rationale and Study Design for Early Rosuvastatin-Ezetimibe Combination Compared with Stepwise Rosuvastatin in High/Very-High Cardiovascular Risk.Archives of Medical Science · 2026
3. Post-stroke Holter-ECG findings beyond atrial fibrillation – A subgroup analysis of the MonDAFIS trialEuropean Heart Journal · 2026
4. The perspective of combining pulsed field ablation and left atrial appendage closureEP Europace · 2026
5. Rapid Clearance of microRNA-371a-3p: A Longitudinal Study of Serum Levels in Patients with Localized Testicular Germ Cell TumorsEuropean Urology Open Science · 2026
6. FIND: a phase-II study to evaluate the efficacy and safety of erdafitinib in FGFR-altered NSCLCClinical Cancer Research · 2026
7. Prophylactic vs Therapeutic Anticoagulation in Hospitalized Patients With COVID-19JAMA Network Open · 2026
8. Results from the Pan-European CIEMAR study: Local Tumour Control After Microwave Ablation of Colorectal Liver Metastases and Exploratory Associations with Ablation Margins and Confirmation SoftwareCardioVascular and Interventional Radiology · 2026
9. First year of ongoing invasive Haemophilus influenzae type b outbreak among middle-aged people who use drugs and people who experience homelessness in Hamburg, Germany, September 2024 to August 2025Eurosurveillance · 2026
10. Sex-Based Differences in the Management and Outcomes of Oesophageal Fistula Following Atrial Fibrillation Ablation: A Subanalysis of the Worldwide POTTER-AF StudyEuropean Heart Journal Open · 2026
11. Molecular characterization of FAM222B as a novel disease gene for dominant cardiovascular laterality defectsScientific Reports · 2026
12. High-dose chemotherapy followed by autologous stem-cell transplantation versus non-myeloablative consolidation in primary CNS lymphoma (MATRix/IELSG43): a randomised phase 3 trialThe Lancet · 2026
13. COnCOmitaNt pulsed field ablation-based pUlmonary vein isolation and lefT atrial appendage closure: the COCONUT studyEP Europace · 2026
14. Intraoperative copy number profiling from ultra-low coverage long-read sequencing for molecular tumor assessment2026
15. OPTIM: a randomized phase II trial of nivolumab followed by nivolumab-ipilimumab or docetaxel at progression in recurrent/metastatic squamous cell carcinoma of the head and neck (OPTIM; AIO-KHT-0117)British Journal of Cancer · 2026
16. Author Correction: Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trialNature Medicine · 2026
17. Efficacy and Tolerability of Zenocutuzumab in Advanced NRG1 Fusion–Positive Cholangiocarcinoma: Results From the eNRGy Phase II TrialJournal of Clinical Oncology · 2026
18. Systematic use of automatic high-density late annotation mapping for ventricular tachycardia ablation procedures - The SLAM-VT studyEP Europace · 2026
19. Cryoballoon based left atrial appendage isolation and closure in patients with atrial fibrillation - The LALALAND Pilot studyEP Europace · 2026
20. Integrating digital health into the EP lab: feasibility, safety, and one-year outcomes of remote support for complex ventricular ablation procedures - results of the REMOTE-VA StudyEP Europace · 2026